Detalhe da pesquisa
1.
A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma.
Cell
; 187(1): 166-183.e25, 2024 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38181739
2.
Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes.
Nat Immunol
; 12(1): 45-53, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21151101
3.
Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumors.
Int J Cancer
; 151(9): 1542-1554, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35737508
4.
Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal immunopathology.
PLoS Pathog
; 16(3): e1008340, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32226027
5.
ER-aminopeptidase 1 determines the processing and presentation of an immunotherapy-relevant melanoma epitope.
Eur J Immunol
; 50(2): 270-283, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31729751
6.
The Era of Checkpoint Inhibition: Lessons Learned from Melanoma.
Recent Results Cancer Res
; 214: 169-187, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31473853
7.
Direct RIG-I activation in human NK cells induces TRAIL-dependent cytotoxicity toward autologous melanoma cells.
Int J Cancer
; 144(7): 1645-1656, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30230526
8.
Chronic retroviral infection of mice promotes tumor development, but CD137 agonist therapy restores effective tumor immune surveillance.
Cancer Immunol Immunother
; 68(3): 479-488, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30635687
9.
Immunoassays for scarce tumour-antigens in exosomes: detection of the human NKG2D-Ligand, MICA, in tetraspanin-containing nanovesicles from melanoma.
J Nanobiotechnology
; 16(1): 47, 2018 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29720199
10.
Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue nevi.
Mod Pathol
; 30(3): 350-356, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27934878
11.
SF3B1 and BAP1 mutations in blue nevus-like melanoma.
Mod Pathol
; 30(7): 928-939, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28409567
12.
The proteasome immunosubunits, PA28 and ER-aminopeptidase 1 protect melanoma cells from efficient MART-126-35 -specific T-cell recognition.
Eur J Immunol
; 45(12): 3257-68, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26399368
13.
Survivin blockade sensitizes rhabdomyosarcoma cells for lysis by fetal acetylcholine receptor-redirected T cells.
Am J Pathol
; 182(6): 2121-31, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23562272
14.
The efficiency of human cytomegalovirus pp65(495-503) CD8+ T cell epitope generation is determined by the balanced activities of cytosolic and endoplasmic reticulum-resident peptidases.
J Immunol
; 189(2): 529-38, 2012 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22706083
15.
Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial.
Nat Med
; 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38689060
16.
Vemurafenib reverses immunosuppression by myeloid derived suppressor cells.
Int J Cancer
; 133(7): 1653-63, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23526263
17.
New developments in biomarkers for melanoma.
Curr Opin Oncol
; 25(2): 145-51, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23334230
18.
Cytotoxic CD4+ T cells in chronic viral infections and cancer.
Front Immunol
; 14: 1271236, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37965314
19.
Targeting the recurrent Rac1P29S neoepitope in melanoma with heterologous high-affinity T cell receptors.
Front Immunol
; 14: 1119498, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36875127
20.
Database for queries of melanoma cohorts with molecular and clinical data.
Pigment Cell Melanoma Res
; 36(2): 252-258, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36382970